Experience of Risk-reducing Salpingo-oophorectomy for a BRCA1 Mutation Carrier and Establishment of a System Performing a Preventive Surgery for Hereditary Breast and Ovarian Cancer Syndrome in Japan: Our Challenges for the Future

Injectable and Oral Contraceptive Use and Cancers of the Breast, Cervix, Ovary, and Endometrium in Black South African Women: Case–Control Study

(2012) Margaret Urban et al.   PLOS MEDICINE

Cross-sectional analysis of germline BRCA1 and BRCA2 mutations in Japanese patients suspected to have hereditary breast/ovarian cancer

(2010) Kokichi Sugano et al.   CANCER SCIENCE

Single-port risk-reducing salpingo-oophorectomy with and without hysterectomy: Surgical outcomes and learning curve analysis

(2010) Pedro F. Escobar et al.   GYNECOLOGIC ONCOLOGY

High Rates of Occult Fallopian Tube Cancer Diagnosed at Prophylactic Bilateral Salpingo-Oophorectomy

(2010) Jane E. Hirst et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality

(2010) Susan M. Domchek   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Meta-analysis of Risk Reduction Estimates Associated With Risk-Reducing Salpingo-oophorectomy in BRCA1 or BRCA2 Mutation Carriers

(2009) T. R. Rebbeck et al.   JNCI-Journal of the National Cancer Institute

Screening for Ovarian Cancer

(2009) Daniel L. Clarke-Pearson   NEW ENGLAND JOURNAL OF MEDICINE

Cost‐effectiveness analysis of prevention strategies for gynecologic cancers in Lynch syndrome

(2008) Janice S. Kwon et al.   CANCER

Hormone Therapy and the Risk of Breast Cancer in BRCA1 Mutation Carriers

(2008) A. Eisen et al.   JNCI-Journal of the National Cancer Institute